Sten Langfeldt

Learn More
BACKGROUND Renal denervation (RDN), treating resistant hypertension, has, in open trial design, been shown to lower blood pressure (BP) dramatically, but this was primarily with respect to office BP. METHOD We conducted a SHAM-controlled, double-blind, randomized, single-center trial to establish efficacy data based on 24-h ambulatory BP measurements(More)
OBJECTIVE To evaluate outcome of invasive gynecological re-interventions after uterine artery embolisation (UAE) in relation to leiomyoma characteristics. DESIGN A cohort of 114 women with symptomatic myomas underwent UAE. Myoma characteristics were determined by contrast-enhanced magnetic resonance imaging (MRI) before and 6 months after treatment. The(More)
OBJECTIVES To investigate, whether renal denervation (RDN) improves arterial stiffness, central blood pressure (C-BP) and heart rate variability (HRV) in patients with treatment resistant hypertension. METHODS ReSET was a randomized, sham-controlled, double-blinded trial (NCT01459900). RDN was performed by a single experienced operator using the Medtronic(More)
Severe stenosis of a renal artery may result in renovascular hypertension associated with shrinkage and poor function of the affected kidney. In such cases percutaneous renal artery revascularisation can be technical difficult. We describe three cases of uncomplicated laparoscopic nephrectomy of renin-producing small kidneys with postoperative improvement(More)
  • 1